Product portfolio

Andarine (S-4) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors (AR) with high selectivity. It stimulates anabolic signaling pathways, promoting lean muscle growth, enhancing bone density, and supporting strength gains, while minimizing androgenic activity in non-target tissues.

AOD9604 is a synthetic analog of the fat-burning segment of human Growth Hormone (hGH). It was specifically developed to retain the lipolytic (fat-reducing) properties of hGH without the undesired growth-promoting or insulin-resistance-inducing effects of the full molecule.

Cardarine (GW-501516) is an orally active, non-steroidal metabolic modulator that selectively binds to the PPARδ (Peroxisome Proliferator-Activated Receptor delta). It regulates the expression of genes involved in fatty acid metabolism, energy expenditure, and oxidative capacity in skeletal muscle.

GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It is renowned for its diverse biological actions, including promoting wound healing, attracting immune cells, and stimulating collagen and glycosaminoglycan synthesis in skin fibroblasts.

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that acts as a potent agonist of the ghrelin receptor. It is extensively researched for its ability to stimulate the pituitary gland to release natural growth hormone (GH) via the G-protein coupled receptor pathway.

Hexarelin is a synthetic hexapeptide growth hormone secretagogue (GHS) that possesses potent GH-releasing activity. It is highly valued in clinical research for its metabolic stability and its secondary effects on cardiovascular function through the activation of the CD36 receptor.

Ipamorelin is a pentapeptide and a selective agonist of the ghrelin/growth hormone secretagogue receptor. It is recognized for its ability to stimulate growth hormone (GH) secretion without significantly affecting prolactin, ACTH, or cortisol levels, making it one of the most targeted secretagogues available.

MK-677 (Ibutamoren) is an orally active, non-peptide growth hormone secretagogue that binds to the ghrelin receptor (GHS-R1a). It stimulates the release of growth hormone and IGF-1, modulating multiple metabolic and signaling pathways involved in tissue growth, repair, and overall endocrine regulation.

Ostarine (MK-2866 / Enobosarm) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors (AR) with high selectivity. It promotes lean muscle growth, enhances bone density, and supports strength gains, while minimizing androgenic activity in non-target tissues.

Testolone (RAD-140) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that selectively binds to androgen receptors (AR) in muscle and bone tissue. It promotes muscle growth, strength, and bone density, while minimizing androgenic effects on non-target tissues.

RAD-150 is an orally active, non-steroidal SARM and an esterified derivative of RAD-140. Its esterified form is designed for extended half-life and more stable blood levels, which may allow for less frequent dosing compared to RAD-140.

Retatrutide (LY3437943) is a cutting-edge, unimolecular triple receptor agonist. It targets the GLP-1, GIP, and glucagon (GCG) receptors, offering unprecedented potential in research involving weight management and metabolic health.